<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Avenacy 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=47139></link><description><![CDATA[Avenacy 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 15 Apr 2026 18:37:10 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/01/12_1028147215_20250107095652_4336422578.png]]></url></image><language>ko-KR</language><item><title><![CDATA[Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1003979</link><description><![CDATA[SCHAUMBURG, Ill.--(Business Wire/Korea Newswire)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today provided an update on recent business highlights and financial performance for 2024 and strategic priorities for 2025 ahead of the Company’s participation in the 43rd Annual J.P. Morgan Healthcare Conference from January 13-16, 2025 in San Fra...]]></description><pubDate>Tue, 07 Jan 2025 10:09:11 +0900</pubDate></item></channel></rss>